Tv6 treatment inhibited cell proliferation in all sarcoma cell lines tested independent on p53 status with IC50 ranging between 1.3 and 5.5 μM at 48 h as determined by using the Wst-1 assay (Table 1 and Supplementary Figure 1). The gene discussed is TP53; the disease is sarcoma.